Imaging of the Diabetic Foot Diagnostic Dilemmas

Foot & Ankle Specialist

Volumn 3, Issue 5, 2010, Pages 249-264

  Loredo, Rebecca ^a   Rahal, Andres ^a   Garcia, Glenn ^a   Metter, Darlene ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Charcot foot; diabetic foot imaging; neuroarthropathy; osteomyelitis

Indexed keywords

ABSCESS; CELLULITIS; DIABETIC FOOT; DIABETIC NEUROPATHY; DIAGNOSTIC IMAGING; HUMAN; METHODOLOGY; NECROSIS; NECROTIZING FASCIITIS; OSTEOMYELITIS; PATHOLOGY; POSTOPERATIVE CARE; PYOMYOSITIS; REVIEW; SKELETAL MUSCLE;

ABSCESS; CELLULITIS; DIABETIC FOOT; DIABETIC NEUROPATHIES; DIAGNOSTIC IMAGING; FASCIITIS, NECROTIZING; HUMANS; MUSCLE, SKELETAL; NECROSIS; OSTEOMYELITIS; POSTOPERATIVE CARE; PYOMYOSITIS;

EID: 79953011500     PISSN: 19386400     EISSN: None     Source Type: Journal    
DOI: 10.1177/1938640010383154     Document Type: Review

References (54)

1. Murphy WA, Totty WG, Destouet JM, et al. Musculoskeletal system. In: Lee JKT, Sagel SS, Stanley RJ, eds. Computed Body Tomography With MRI Correlation. New York, NY: Raven Press; 1989: 899-987.
2. Moore TE, Yuh WTC. Magnetic resonance imaging of the diabetic foot. In: Bloem JL, Sartoris DJ, eds. MRI and CT of the Musculoskeletal System: A Text-Atlas. Baltimore, MD: Williams & Wilkins; 1992: 207-216.
3. Maurer AH, Millmond SH, Knight LC, et al. Infection in diabetic osteoarthropathy: use of indium-labeled leukocytes for diagnosis. Radiology. 1986; 161: 221-225.
4. Palestro CJ, Mehta HH, Patel M., et al. Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99m sulfur colloid scintigraphy. J Nucl Med. 1998; 39: 346-350.
5. Love C., Din AS, Tomas MB, et al. Radionuclide bone imaging: an illustrative review-1. Radiographics. 2003; 23: 341-358.
6. Schauwecker DS The scintigraphic diagnosis of osteomyelitis. AJR Am J Roentgenol. 1992; 158: 9-18.
7. Devillers A., Miosan A., Jean S., et al. Tecnetium-99m-HMPAO leukocyte scintigraphy for the diagnosis of bone and joint infections: a retrospective study in 116 patients. Eur J Nucl Med. 1995;22: 302-307.
8. Abreu SH Skeletal uptake of indium-111 labeled white blood cells. Semin Nucl Med. 1989; 19: 152-155.
9. Filippi L., Schillaci O. Usefulness of hybrid SPECT/CT in Tc-99m HMPAOlabeled leukocyte scintigraphy for bone and joint infections. J Nucl Med. 2006; 47(12):1908-1913.
10. Van der Wall H. Assessment of infection. In: Murray IPC, Ell PJ, eds. Nuclear Medicine in Clinical Diagnosis and Treatment. New York, NY: Churchill Livingstone; 1994: 963-981.
11. Lipsky BA, Berendt AR, Deery HG, et al. Diagnosis and treatment of diabetic foot infections. Plast Reconstr Surg. 2006; 117: 212S-238S.
12. Yuh WTX, Corson JD, Baraniewski HM, et al. Osteomyelitis of the foot in diabetic patients: evaluation with plain film, 99mTcMDP bone scintigraphy, and MR imaging. AJR Am J Roentgenol. 1989; 152: 795-800.
13. Wang A., Weinstein D., Greenfield L., et al. MRI and diabetic foot infections. Magn Reson Imaging. 1990; 3: 219-230.
14. Newman LG, Waller, Palestro CJ, et al. Leukocyte scanning with in-111 is superior to magnetic resonance imaging in diagnosis of clinically unsuspected osteomyelitis in diabetic foot ulcers. Diabetes Care. 1992; 15: 1527-1530.
15. Croll SD, Nicholas GG, Osborn MA, Wasser TE, Jones S. Role of magnetic resonance imaging in the diagnosis of osteomyelitis in diabetic foot infections. J Vasc Surg. 1996; 24(2):266-270.
16. Weinstein D., Wang A., Chambers R., et al. Evaluation of magnetic resonance imaging in the diagnosis of osteomyelitis in diabetic foot infections. Foot Ankle Int. 1993; 14: 18-22.
17. deWinters F., van de Wiele C., Vogelaers D., de Smet K., Verdonk R., Dierckx, RA Fluorine-28 fluorodeoxyglucose-positron emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections. J Bone Joint Surg Am. 2001; 83(5):651-660.
18. Dumarey N., Egrise D., Blocklet D., et al. Imaging infections with 18F-FDG-labeled leukocyte PET/CT: initial experience in 21 patients. J Nucl Med. 2006;47(4):625-632.
19. Basu S., Chryssicos T., Houseni M., et al. Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft tissue infection? Nucl Med Commun. 2007; 28(6):465-472.
20. Schwegler B., Stumpe KD, Weishaupt D., et al. Unsuspected osteomyelitis is frequent in persistent diabetic foot ulcer and better diagnosed by MRI than by 18F-FDG PET or 99mTC-MOAB. J Intern Med. 2008; 263(1):99-106.
21. Höpfner S., Krolak C., Kessler S., et al. Preoperative imaging of charcot neuroarthropathy in diabetic patients: comparison of ring PET, hybrid PET, and magnetic resonance imaging. Foot Ankle Int. 2004; 25(12):890-895.
22. Zlatkin MB, Pathria M., Sartoris DJ, et al. The diabetic foot. Radiol Clin North Am. 1987; 25: 1095.
23. Sello EJ Current concepts review: diagnostic imaging of the diabetic foot. Foot Ankle Int. 2009; 30(6):568-576.
24. Moore TE, Yuh WTC, Kathol MH, et al. Abnormalities of the foot in patients with diabetes mellitus: findings on MR imaging. AJR Am J Roentgenol. 1991; 157: 813-816.
25. Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006; 29: 1288-1293.
26. Spaeth HJ, Dardani M. Magnetic resonance imaging of the diabetic foot. Magn Reson Imaging Clin N Am. 1994; 2(1):123-130.
27. Alazraki N., Dries D., Datz F., Lawrence P., Greenberg E., Taylor A. Jr. Value of a 24-hour (four-phase bone scan) in assessing osteomyelitis in patients with peripheral vascular disease. J Nucl Med. 1985; 26: 711-717.
28. Tronco G., Tomas MB, Palestro CJ Four-phase bone scintigraphy and osteomyelitis: a reevaluation. Clin Nucl Med. 1999; 24(3):216.
29. Keidar Z., Militianu D., Melamed E., Bar-Shalom R., Israel O. The diabetic foot: initial experience with F-18-FDG PET/CT. J Nucl Med. 2005; 46(3):444-449.
30. Vartanians VM, Karchmer AW, Giurini JM, Rosenthal DI Is there a role for imaging in the management of patients with diabetic foot? Skeletal Radiol. 2009; 38(7):633-636.
31. Unger E., Moldofsky P., Gatenby R., Hartz W., Broder G. Diagnosis of osteomyelitis by MR imaging. AJR Am J Roentgenol. 1988; 150(3):605-610.
32. Erdman WA, Tamburro F., Jayson HT, et al. Osteomyelitis: characteristics and pitfalls of diagnosis with MR imaging. Radiology. 1991; 180(8):533-539.
33. Morrison WB, Schweitzer ME, Wapner KL, et al. Osteomyelitis in feet of diabetics: clinical accuracy, surgical utility, and cost-effectiveness of MR imaging. Radiology. 1995; 196: 557-564.
34. Tan PL, Teh J. MRI of the diabetic foot: differentiation of infection from neuropathic change. Br J Radiol. 2007; 80(959):939-948.
35. Palestro CJ, Tomas MB Scintigraphic evaluation of the diabetic foot. In: Freeman LM, ed. Nuclear Medicine Annual 2000. Philadelphia, PA: Lippincott Williams & Wilkins; 2000: 143-172.
36. Dumarey N., Egrise D., Blocklet D., et al. Imaging infection with F-18-FDG-labeled leukocyte PET/CT: initial experience in 21 patients. J Nucl Med. 2006;47: 625-632.
37. Basu S., Chryssikos T., Moghadam-Kia S., Zhuang H., Torigian D., Alavi A. Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. Semin Nucl Med. 2009; 39(1):36-51.
38. Schmind MR, Kossman T., Duewell S. Differentiation of necrotizing fasciitis and cellulitis using MR imaging. AJR Am J Roentgenol. 1998; 170(3):615-620.
39. Nguyen VD The radiologic spectrum of abnormalities of the foot in diabetic patients. Can Assoc Radiol J. 1992; 43(5):333-339.
40. Struk D., Munk P., Lee M., Ho S., Worsley D. Imaging of soft tissue infections. Radiol Clin North Am. 2001; 39: 277-301.
41. Walshaw C., Deans H. CT findings in necrotizing fasciitis: a report of four cases. Clin Radiol. 1996; 51: 429-432.
42. Donnelly L., Frush D., O'Hara S., Bissett G. Necrotizing fasciitis: an atypical cause of acute abdomen in an immunocompromised child. Pediatr Radiol. 1998; 28: 109-111.
43. Becker M., Zbaren P., Hermans R., et al. Necrotizing fasciitis of the head and neck: role of CT in diagnosis and management. Radiology. 1997; 202: 471-476.
44. Seok JH, Jee WH, Chun KA Necrotizing fasciitis versus pyomyositis: discrimination with using MR imaging. Korean J Radiol. 2009; 10(2):121-128.
45. Miller T., Randolph D., Staron R., Feldman F., Cushin S. Fat-suppressed MRI of musculoskeletal infection: fast T2-weighted techniques versus gadolinium-enhanced T1-weighted images. Skeletal Radiol. 1997; 26: 654-658.
46. May DA, Disler DG, Jones EA, Balkissoon AA, Manaster BJ Abnormal signal intensity in skeletal muscle at MR imaging: patterns, pearls, and pitfalls. Radiographics. 2000; 20: 295-315.
47. Nunez-Hoyo M., Gardner CL, Motta AO, Ashmead JW Skeletal muscle infarction in diabetes: MR findings. J Comput Assist Tomogr. 1993; 17: 986-988.
48. Van Slyke MA, Ostrov BE MRI evaluation of diabetic muscle infarction. Magn Reson Imaging. 1995; 13: 325-329.
49. Kiers L. Diabetic muscle infarction: magnetic resonance imaging (MRI) avoids the need for biopsy [letter]. Muscle Nerve. 1995; 18: 129-130.
50. Chason DP, Fleckenstein JL, Burns DK, Rojas G. Diabetic muscle infarction: radiologic evaluation. Skeletal Radiol. 1996; 25: 127-132.
51. Fayad LM, Patra A., Fishman EK Value of 3D CT in defining skeletal complications of orthopedic hardware in the postoperative patient. AJR Am J Roentgenol. 2009; 193: 1155-1163.
52. Berquist TH, Brown ML, Fitzgerald R., et al. Magnetic resonance imaging: application in musculoskeletal infection. Magn Reson Imaging. 1985; 3: 219-230.
53. Zgonis T., Stapleton JJ, Roukis TS A stepwise approach to the surgical management of severe diabetic foot infections. Foot Ankle Spec. 2008; 1: 46-53.
54. Fugitt B., Puckett ML, Quigley MM, Kerr SM Necrotizing fasciitis. Radiographics. 2004;24: 1472-1476.